ST. PAUL, Minn., and CHICAGO--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII), will present 12-month data from its COMPLIANCE 360° study at The American College of Cardiology’s (ACC's) 61st Annual Scientific Session & Expo, McCormick Place South, in Chicago, March 24–27, 2012. The COMPLIANCE 360° study is comparing treatment of above-the-knee calcified lesions using CSI’s Diamondback™ Orbital Atherectomy System, followed by low-pressure balloon angioplasty, to balloon angioplasty alone.
